Henan Lingrui Pharmaceutical Co Ltd (600285) — Strategic Asset Allocation Index
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Strategic Asset Allocation Index of 26.5% as of June 2023. Strategic assets (PP&E of CN¥675.07 Million plus long-term investments of CN¥-) total CN¥675.07 Million, measured against net assets of CN¥2.55 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Henan Lingrui Pharmaceutical Co Ltd Strategic Asset Allocation Index (2000–2021)
This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 26.5%, representing strategic assets of CN¥675.07 Million against net assets of CN¥2.55 Billion CNY. Explore 600285 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Henan Lingrui Pharmaceutical Co Ltd (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Henan Lingrui Pharmaceutical Co Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Henan Lingrui Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 32.1% | CN¥732.92 Million | CN¥732.92 Million | CN¥- | CN¥2.29 Billion | ▲ +0.6 pp |
| 2020 | 31.4% | CN¥730.03 Million | CN¥730.03 Million | CN¥- | CN¥2.32 Billion | ▼ -3.1 pp |
| 2019 | 34.5% | CN¥766.04 Million | CN¥766.04 Million | CN¥- | CN¥2.22 Billion | ▼ -16.0 pp |
| 2018 | 50.5% | CN¥1.06 Billion | CN¥780.11 Million | CN¥278.14 Million | CN¥2.09 Billion | ▼ -4.9 pp |
| 2017 | 55.4% | CN¥1.22 Billion | CN¥807.30 Million | CN¥413.34 Million | CN¥2.20 Billion | ▲ +6.3 pp |
| 2016 | 49.1% | CN¥1.04 Billion | CN¥670.05 Million | CN¥367.25 Million | CN¥2.11 Billion | ▼ -28.9 pp |
| 2015 | 78.0% | CN¥1.34 Billion | CN¥533.75 Million | CN¥811.08 Million | CN¥1.72 Billion | ▲ +47.6 pp |
| 2014 | 30.5% | CN¥475.26 Million | CN¥475.26 Million | CN¥- | CN¥1.56 Billion | ▼ -26.2 pp |
| 2013 | 56.7% | CN¥558.12 Million | CN¥558.12 Million | CN¥- | CN¥984.89 Million | ▼ -6.5 pp |
| 2012 | 63.1% | CN¥440.01 Million | CN¥440.01 Million | CN¥- | CN¥696.97 Million | ▲ +9.4 pp |
| 2011 | 53.7% | CN¥367.54 Million | CN¥367.54 Million | CN¥- | CN¥684.01 Million | ▲ +8.3 pp |
| 2010 | 45.5% | CN¥322.78 Million | CN¥322.78 Million | CN¥- | CN¥709.69 Million | ▼ -2.2 pp |
| 2009 | 47.6% | CN¥307.61 Million | CN¥307.61 Million | CN¥- | CN¥645.69 Million | ▼ -1.5 pp |
| 2008 | 49.2% | CN¥270.21 Million | CN¥270.21 Million | CN¥- | CN¥549.72 Million | ▲ +5.3 pp |
| 2007 | 43.8% | CN¥253.76 Million | CN¥253.76 Million | CN¥- | CN¥579.24 Million | ▼ -6.5 pp |
| 2006 | 50.3% | CN¥244.63 Million | CN¥244.63 Million | CN¥- | CN¥486.67 Million | ▼ -0.2 pp |
| 2005 | 50.5% | CN¥242.10 Million | CN¥242.10 Million | CN¥- | CN¥479.80 Million | ▲ +8.1 pp |
| 2004 | 42.4% | CN¥198.82 Million | CN¥198.82 Million | CN¥- | CN¥469.45 Million | ▲ +5.7 pp |
| 2003 | 36.6% | CN¥165.49 Million | CN¥165.49 Million | CN¥- | CN¥451.69 Million | ▲ +1.7 pp |
| 2002 | 34.9% | CN¥145.49 Million | CN¥145.49 Million | CN¥- | CN¥416.74 Million | ▲ +10.8 pp |
| 2001 | 24.1% | CN¥96.70 Million | CN¥96.70 Million | CN¥- | CN¥401.79 Million | ▲ +6.7 pp |
| 2000 | 17.4% | CN¥70.96 Million | CN¥70.96 Million | CN¥- | CN¥408.46 Million | — |